Although CCL2 has been originally thought to have an inhibitory effect on ovarian cancer progression [94,95,96], recent studies have indicated that CCL2 increases invasion of ovarian cancer cells and resistance to chemotherapy [97,98]. Here, CCL2 is linked to ovarian carcinoma.